What happened
Ternium S.A. (NYSE: TX) more than doubled nine-month operating income to $1.40 billion from $546.45 million a year earlier.
In the unaudited statements for the nine months ended Sept. 30, net sales rose to $12.92 billion from $11.83 billion a year earlier. Profit for the period reached $1.20 billion against $131.78 million, and earnings per share attributable to shareholders were $0.43 against $0.15.
Profit before income tax rose to $1.35 billion from $493.66 million. Income tax expense fell to $144.88 million from $361.88 million.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Operating income, nine months | $1.40 billion | from $546.45 million | SEC 6-K |
| Net sales, nine months | $12.92 billion | from $11.83 billion, +9.2% | Calculated from SEC 6-K |
| Profit for the period, nine months | $1.20 billion | from $131.78 million | SEC 6-K |
| Net cash from operating activities, nine months | $1.09 billion | from $1.79 billion, -39.2% | Calculated from SEC 6-K |
| Usiminas litigation provision, Sept. 30, 2026 | $619.10 million | SEC 6-K |
Read more: Ternium (TX) company research
Why it matters
The profit rebound did not carry into cash. OptimistFi calculates that operating margin rose to 10.8% from 4.6%. By its calculation, net cash from operating activities fell 39.2% to $1.09 billion from $1.79 billion.
The cash flow statement shows a working-capital outflow of $798.3 million, against an inflow of $900.88 million a year earlier. Capital expenditures dropped to $1.23 billion from $2.04 billion.
Ternium also added debt. Proceeds from borrowings were $768.49 million, mainly a $500 million syndicated loan at Ternium Mexico for the Pesquería investment plan. Non-current borrowings stood at $2.31 billion on Sept. 30 versus $1.81 billion on Dec. 31, 2025.
The Usiminas litigation is the main caveat. The provision for the CSN lawsuit stands at $619.1 million, up from $527.6 million on Dec. 31, 2025, after a $91.5 million charge in the period. If CSN finally prevails, the filing puts the amounts potentially payable at $457.2 million for Ternium Investments and $161.9 million for Ternium Argentina, at the Sept. 30 exchange rate.
OptimistFi has argued that Ternium must turn volatile demand into through-cycle cash. The margin rebound argues against 2025's compression becoming permanent, while weaker operating cash flow leaves the cash test open.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
Ternium's next quarterly report will show whether operating income held up and whether the working-capital outflow reversed. It will also show whether the Usiminas provision rose again from its Sept. 30 level.
More from OptimistFi
From OptimistFi Perps
- Stock perps vs tokenized stocks: how US shares trade around the clock
- Weekend market prices: US stock indexes, gold and oil now
- Perps news: leveraged stocks, gold, FX and crypto on-chain
- Prop firms that fund crypto and stock perps traders: rules, prices and payouts
- Top perps movers today: stocks, commodities, FX and indices
- Open interest live: crypto and stock perps by exchange
Sources
- Ternium S.A. Form 6-K with consolidated condensed interim financial statements as of Sept. 30, 2026 — Unaudited income statement, financial position, cash flows and notes for the nine months ended Sept. 30, 2026 and 2025, dated Nov. 3, 2026.
Explore OptimistFi research on Ternium S.A.: https://optimistfi.com/stocks/TX
Browse Ternium S.A. company coverage and explore the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
Find available research on the Ternium S.A. company page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
